Incidence and outcomes of hospital-associated coronavirus disease 2019 (COVID-19) before and after emergence of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant.
作者信息
Williams Victoria R, Tan Charlie, Kozak Robert, Leis Jerome A
机构信息
Infection Prevention and Control, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Division of Infectious Diseases, Department of Medicine, University of Toronto, Ontario, Canada.
出版信息
Infect Control Hosp Epidemiol. 2023 Oct;44(10):1698-1700. doi: 10.1017/ice.2023.29. Epub 2023 Mar 6.
Abstract
摘要
相似文献
1
Incidence and outcomes of hospital-associated coronavirus disease 2019 (COVID-19) before and after emergence of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）奥密克戎变种出现前后医院获得性2019冠状病毒病（COVID-19）的发病率及转归
Infect Control Hosp Epidemiol. 2023 Oct;44(10):1698-1700. doi: 10.1017/ice.2023.29. Epub 2023 Mar 6.
2
Air dispersal of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Implications for hospital infection control during the fifth wave of coronavirus disease 2019 (COVID-19) due to the SARS-CoV-2 omicron variant in Hong Kong.空气传播严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）：香港第五波由 SARS-CoV-2 奥密克戎变异株引起的 2019 冠状病毒病（COVID-19）期间对医院感染控制的影响。
Infect Control Hosp Epidemiol. 2023 Aug;44(8):1321-1324. doi: 10.1017/ice.2022.258. Epub 2022 Oct 24.
3
Characterization of healthcare-associated infections with the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant at a tertiary healthcare center.在一家三级医疗中心对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）奥密克戎变种所致医疗保健相关感染的特征分析
Infect Control Hosp Epidemiol. 2023 Jan;44(1):133-135. doi: 10.1017/ice.2022.138. Epub 2022 May 26.
4
Survey of coronavirus disease 2019 (COVID-19) infection control policies at leading US academic hospitals in the context of the initial pandemic surge of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant.对严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）奥密克戎变异株引发的大流行初期，美国领先的学术医院中针对 2019 年冠状病毒病（COVID-19）感染控制政策的调查。
Infect Control Hosp Epidemiol. 2023 Apr;44(4):597-603. doi: 10.1017/ice.2022.155. Epub 2022 Jun 16.
5
SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022.SARS-CoV-2 感染和≥18 岁成年人住院情况，按疫苗接种状态，在 SARS-CoV-2 B.1.1.529（奥密克戎）变异株流行之前和期间——加利福尼亚州洛杉矶县，2021 年 11 月 7 日-2022 年 1 月 8 日。
MMWR Morb Mortal Wkly Rep. 2022 Feb 4;71(5):177-181. doi: 10.15585/mmwr.mm7105e1.
6
Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS-CoV-2 variants.与 SARS-CoV-2 三种主要变异株相关的临床结果和系统进化分析。
Eur J Clin Invest. 2023 Sep;53(9):e14004. doi: 10.1111/eci.14004. Epub 2023 May 2.
7
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间，加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局，期间 B.1.617.2（德尔塔）和 B.1.1.529（奥密克戎）变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
8
Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.接种疫苗的造血干细胞移植受者 COVID-19 结局良好：单中心经验。
Transpl Infect Dis. 2023 Jun;25(3):e14024. doi: 10.1111/tid.14024. Epub 2023 Feb 7.
9
Trends in Confirmed COVID-19 Cases in the Korean Military Before and After the Emergence of the Omicron Variant.奥密克戎变异株出现前后韩国军人中确诊 COVID-19 病例的趋势。
J Korean Med Sci. 2022 Aug 29;37(34):e260. doi: 10.3346/jkms.2022.37.e260.
10
[Analyze the clinical characteristics of mild and severe SARS-CoV-2 infected patients based on the local Omicron variant epidemic].基于本地奥密克戎变异株流行情况分析新型冠状病毒感染轻症和重症患者的临床特征
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Jan;35(1):32-36. doi: 10.3760/cma.j.cn121430-20220406-00339.
引用本文的文献
1
Utility of routine post-admission testing for SARS-CoV-2 in a rehabilitation facility.康复机构中SARS-CoV-2入院后常规检测的效用
Antimicrob Steward Healthc Epidemiol. 2024 Feb 12;4(1):e21. doi: 10.1017/ash.2024.14. eCollection 2024.
本文引用的文献
1
Impact of universal admission testing for severe acute respiratory coronavirus 2 (SARS-CoV-2) in era of the omicron variant.在奥密克戎变异株时代，对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）进行普遍入院检测的影响。
Infect Control Hosp Epidemiol. 2023 Jan;44(1):102-105. doi: 10.1017/ice.2022.273.
2
Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron lineages BA.2, BA.2.12.1, BA.2.75 and BA.5.二价mRNA疫苗加强针可诱导针对奥密克戎谱系BA.2、BA.2.12.1、BA.2.75和BA.5的强大抗体免疫。
Cell Discov. 2022 Oct 11;8(1):108. doi: 10.1038/s41421-022-00473-4.
3
Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods - United States, April 2020-June 2022.在奥密克戎和德尔塔变异株流行期间因 COVID-19 住院的患者的死亡率风险 - 美国，2020 年 4 月-2022 年 6 月。
MMWR Morb Mortal Wkly Rep. 2022 Sep 16;71(37):1182-1189. doi: 10.15585/mmwr.mm7137a4.
4
Current Effective Therapeutics in Management of COVID-19.新型冠状病毒肺炎管理中的当前有效治疗方法
J Clin Med. 2022 Jul 1;11(13):3838. doi: 10.3390/jcm11133838.
5
Association of Omicron vs Wild-type SARS-CoV-2 Variants With Hospital-Onset SARS-CoV-2 Infections in a US Regional Hospital System.奥密克戎变异株与野生型 SARS-CoV-2 变异株与美国区域性医院系统中 SARS-CoV-2 医院获得性感染的关联。
JAMA. 2022 Jul 19;328(3):296-298. doi: 10.1001/jama.2022.9609.
6
Characterization of healthcare-associated infections with the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant at a tertiary healthcare center.在一家三级医疗中心对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）奥密克戎变种所致医疗保健相关感染的特征分析
Infect Control Hosp Epidemiol. 2023 Jan;44(1):133-135. doi: 10.1017/ice.2022.138. Epub 2022 May 26.
7
SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance.SARS-CoV-2 奥密克戎变异株：流行病学特征、生物学特性及临床意义。
Front Immunol. 2022 Apr 29;13:877101. doi: 10.3389/fimmu.2022.877101. eCollection 2022.
8
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.美国奥密克戎、德尔塔和阿尔法 SARS-CoV-2 变异株的 mRNA 疫苗对新冠病毒的临床严重程度和有效性：前瞻性观察研究。
BMJ. 2022 Mar 9;376:e069761. doi: 10.1136/bmj-2021-069761.
9
Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021.与德尔塔变异株相比，奥密克戎 BA.1 变异株引起的 SARS-CoV-2 病例的连续间隔时间更短，荷兰，2021 年 12 月 13 日至 26 日。
Euro Surveill. 2022 Feb;27(6). doi: 10.2807/1560-7917.ES.2022.27.6.2200042.
10
Indoor Air Changes and Potential Implications for SARS-CoV-2 Transmission.室内空气变化及其对严重急性呼吸综合征冠状病毒2传播的潜在影响。
JAMA. 2021 May 25;325(20):2112-2113. doi: 10.1001/jama.2021.5053.
Zotero 插件